AVECHO BIOTECHNOLOGY LIMITED |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.003 AUD | -25.00% |
|
-.--% | -14.29% |
| May. 16 | Avecho Biotechnology Doses First Patient in Phase III Anti-Insomnia Drug Trial | MT |
| Mar. 25 | Avecho Biotechnology Begins Patient Recruitment for Phase Three Anti-Insomnia Drug Trial | MT |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
End-of-day quotes
End-of-day quotes
Sector Other Biotechnology & Medical Research
| Capi. | Sales growth | Profitability | Finances | EV / Sales | P/E ratio | |
|---|---|---|---|---|---|---|
| 6.31M | - | - | - | - | - | |
| 54.64B | - | |||||
| 39.92B | ||||||
| 38.82B | ||||||
| 26.86B | ||||||
| 26.22B |
